Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for postoperative immobilization after arthroscopic rotator cuff repair
NL-OMON36425Active, not recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in rotator cuff tear, Supraspinatus tear (SST) and infraspinatus tendon tear (2 arms), sponsored by HagaZiekenhuis. Primary endpoint: Postoperative pain and discomfort. Started Jul 2012; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
rotator cuff tearSupraspinatus tear (SST)infraspinatus tendon tear
Beyond the preview
Go deeper on NL-OMON36425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36425.